Observations
2016_01_28 Data Snapshot
Table 1. Get Full Table
| Barcode | UUID | Date | Type | Category | Notes |
|---|---|---|---|---|---|
| TCGA-06-0178 | 53abce1d-7e33-4ebd-832f-f3789f67377f | 07/30/2010 | GBM | Normal class but appears diseased | [schaefc]: Genomic data resembles tumor data |
| TCGA-06-0240-01A-01 | (none) | 07/30/2010 | GBM | Tumor class but appears normal | [schaefc]: Dx slide resembles normal tissue |
| TCGA-06-0240-01A-02 | 58955a9c-b15c-41a1-8a98-bc997926c988 | 07/30/2010 | GBM | Tumor class but appears normal | [schaefc]: Dx slide resembles normal tissue |
| TCGA-06-0240-01A-03 | bfd417c5-c8f4-4759-a250-ee8f8aa57272 | 07/30/2010 | GBM | Tumor class but appears normal | [schaefc]: Dx slide resembles normal tissue |
| TCGA-06-A6S1-10A-01D | 0ff5d286-e53d-484e-9400-415687d729b7 | 11/19/2013 | GBM | General | DNA analyte UUID: 0FF5D286-E53D-484E-9400-415687D729B7 was involved in an extraction protocol deviation wherein isopropanol precipitation was used as a means of buffer exchange on the column-eluted analyte. |
| TCGA-08-0386-11 | (none) | 07/30/2010 | GBM | Normal class but appears diseased | [schaefc]: Genomic data resembles tumor data |
| TCGA-12-0615 | 141a1ef1-9be6-46d1-b445-305b222727d2 | 10/28/2010 | GBM | Item may not meet study protocol | Case identified (by Duke) as a secondary GBM; original annotation 06/22/09 |
| TCGA-12-0662 | a3cc2845-8a44-4b50-8a3e-17a3c2c3e077 | 10/28/2010 | GBM | Item may not meet study protocol | Case identified (by Duke) as a secondary GBM; original annotation 06/22/09 |
| TCGA-12-0691 | bb0aca6b-55ab-4b24-8e64-29e0c96a9862 | 10/28/2010 | GBM | Item may not meet study protocol | Case identified (by Duke) as a secondary GBM; original annotation 06/22/09 |
| TCGA-12-0769 | 29b34909-9cdc-4a52-b0ab-fa99f3ab17bb | 10/28/2010 | GBM | Item may not meet study protocol | Case identified (by Duke) as a secondary GBM; original annotation 06/22/09 |
| TCGA-12-0818 | e57b296a-80e9-4446-a3d1-3dbfeaf04f5e | 10/28/2010 | GBM | Item may not meet study protocol | Case identified (by Duke) as a secondary GBM; original annotation 06/22/09 |
| TCGA-12-0819 | 025a7401-a65d-4ea0-8b4e-0ba775b0322a | 10/28/2010 | GBM | Item may not meet study protocol | Case identified (by Duke) as a secondary GBM; original annotation 06/22/09 Case identified (by Duke) as a secondary GBM; original annotation 06/22/14 |
| TCGA-27-1838 | 6fc6b9ca-84d8-4647-bbc8-c5ab472b1c02 | 10/09/2015 | GBM | Item may not meet study protocol | Pt treated with oxcarbazepine 11 days prior to procurement. According to the NIH, this drug is an anticonvulsant to treat seizures. |
| TCGA-27-2523 | 737b35e1-d668-4fce-9b6e-76946c7952b6 | 10/09/2015 | GBM | Item may not meet study protocol | Pt treated with dexmethasone and phenytoin sodium 6 days prior to procurement. According to the NIH, dexmethasone is an ancillary or hormone drug; SEER lists phenytoin sodium as an anticonvulsant to treat seizures. |